Seven years after scientists successfully managed to adapt a gene editing system used by bacteria into one that can be easily used in labs to edit human genes, we take a look at some of the emerging applications and ethical issues of CRISPR-Cas9. We talk to the head of the European Group on Ethics in Science and New Technologies about whether the simplicity and low cost of CRISPR means that there is potential for misuse and what should be done about this. We find out how scientists have used CRISPR to create cows lacking two sugars that trigger the human immune system, leading to hopes of longer-lasting heart valves for transplant patients and healthier red meat. And we speak to researchers who are using CRISPR to improve other gene editing technologies.
We need an active public debate on the ethics of gene editing technology to realise its potential and prevent it being used in nefarious ways, for example by the military and amateur scientists, and to take cultural differences into account, according to Professor Christiane Woopen, executive director of the Centre for Ethics, Rights, Economics and Social Sciences of Health (CERES) at Germany’s University of Cologne.
Thanks to the ‘cut and paste’ gene editing technique CRISPR, scientists are homing in on a cure for sickle cell disease - a genetic blood disorder - while other research is looking at how to expand the potential of CRISPR-based treatments.
The world looks very different from this time last year. The coronavirus pandemic has highlighted the centrality of science, research and innovation, accelerated some changes already in the works, but also exposed our weaknesses. In September, Horizon looks at how the pandemic is reshaping Europe in areas including health research, work, tech, transport and food – and how research can contribute to Europe’s recovery over the coming years. We will also be covering the European Research & Innovation Days at the end of the month, which will bring together scientists, policymakers, entrepreneurs and citizens to debate how research and innovation can ensure that the transition to a post-coronavirus society is sustainable, inclusive and resilient.
In August, Horizon looks at one of the features that makes Earth unique and habitable: plate tectonics. We explore what we know – and still don’t know – about how the shifting plates beneath our feet shape our planet. We speak to researcher Dr Kate Rychert, who wants to understand what makes a plate plate-like, and delve into one of the outstanding mysteries in the subject – how and why plate tectonics began. We find out about the link between mountain formation, erosion and climate change, and we look at what moonquakes and marsquakes can reveal about tectonic activity elsewhere.
Leuven, Belgium, has been named the 2020 European Capital of Innovation for its use of innovation to improve residents’ lives.
The world’s pressing need is a vaccine to fight the current threat of Covid-19, but ultimately we may be able to develop a pan-coronavirus vaccine, Sunetra Gupta, a professor of theoretical epidemiology at the University of Oxford, UK, said at the European Commission’s annual research event.
'Frontier research' scientists share how they are fighting Covid-19.
The Belgian city won the €1 million iCapital cash prize, while runner-up prizes went to Cluj-Napoca, Espoo, Helsingborg, Vienna and Valencia.
Dr Kate Rychert studies ocean plate structures.